CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

Corbus Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

05 8 2025 05:00:01 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress

30 7 2025 05:00:01 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals Initiates Multiple Ascending Dose Portion of Phase 1 Study of Highly Peripherally Restricted CB1 Inverse Agonist CRB-913 for the Treatment of Obesity

30 6 2025 05:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab

25 6 2025 05:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium

24 6 2025 13:05:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

22 5 2025 05:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals Names Industry Veteran Rachelle Jacques as Board Chair

19 5 2025 05:00:00 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 2025 RBC Capital Markets Global Healthcare Conference

08 5 2025 05:00:01 提供 Nasdaq GlobeNewswire

Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update

06 5 2025 05:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

07 4 2025 06:56:39 提供 NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

03 4 2025 07:04:20 提供 NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

01 4 2025 07:34:46 提供 NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

31 3 2025 06:45:10 提供 NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

28 3 2025 07:27:20 提供 NetDania Notify

Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity

28 3 2025 05:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

21 3 2025 06:47:57 提供 NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

20 3 2025 06:45:04 提供 NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

19 3 2025 06:50:27 提供 NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

18 3 2025 08:37:18 提供 NetDania Notify

NetDania - New 12 months Low: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

13 3 2025 08:52:18 提供 NetDania Notify